Literature DB >> 11703288

Social coping strategies associated with quality of life decrements among psoriasis patients.

S R Rapp1, C A Cottrell, M R Leary.   

Abstract

BACKGROUND: Individuals with psoriasis often report significant psychological distress, physical disability, social strain and reduced quality of life. Little is known about how they cope with the illness.
OBJECTIVE: The primary aim of this study is to determine whether patients' efforts to cope with psoriasis are associated with better or worse health-related quality of life (HRQL).
METHODS: Focus groups identified seven commonly used coping strategies that were subsequently measured, along with HRQL and other variables, in a survey of 318 individuals with psoriasis.
RESULTS: Results revealed: (i) that psoriasis is associated with decrements in all quality of life domains that were assessed, and (ii) that commonly used coping strategies such as telling others about psoriasis, covering the lesions and avoiding people were associated with greater decrements in HRQL after controlling for covariates; however, telling others that psoriasis is not contagious was associated with smaller HRQL decreases.
CONCLUSIONS: How patients cope with the social aspects of psoriasis is associated with their quality of life.

Entities:  

Mesh:

Year:  2001        PMID: 11703288     DOI: 10.1046/j.1365-2133.2001.04444.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

1.  Exploring Coping Strategies for Patients With Hidradenitis Suppurativa.

Authors:  Joslyn S Kirby; Mia Sisic; Jerry Tan
Journal:  JAMA Dermatol       Date:  2016-10-01       Impact factor: 10.282

Review 2.  Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Authors:  Gil Yosipovitch; Mark B Y Tang
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque Psoriasis.

Authors:  Mark Lebwohl; Norman Preston; Ronald W Gottschalk
Journal:  J Clin Aesthet Dermatol       Date:  2012-02

4.  Psychological Distress, Alexithymia and Alcohol Misuse in Patients with Psoriasis: A Cross-Sectional Study.

Authors:  Ourania Founta; Karoline Adamzik; Anne-Marie Tobin; Brian Kirby; David Hevey
Journal:  J Clin Psychol Med Settings       Date:  2019-06

5.  Evaluation of Social Anxiety Levels and Related Factors in Psoriasis Patients: A Controlled, Cross-Sectional Study.

Authors:  Fatma Elif Yildirim; Sıla Şeremet; Fatma Şule Afşar; İrem Yildiz; Esin İyidoğan
Journal:  Noro Psikiyatr Ars       Date:  2020-01-27       Impact factor: 1.339

6.  Quality of life in patients with psoriasis.

Authors:  Monali J Bhosle; Amit Kulkarni; Steven R Feldman; Rajesh Balkrishnan
Journal:  Health Qual Life Outcomes       Date:  2006-06-06       Impact factor: 3.186

7.  The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.

Authors:  Richard Shikiar; Mary Kaye Willian; Martin M Okun; Christine S Thompson; Dennis A Revicki
Journal:  Health Qual Life Outcomes       Date:  2006-09-27       Impact factor: 3.186

8.  Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.

Authors:  Dennis A Revicki; Alan Menter; Steven Feldman; Miriam Kimel; Neesha Harnam; Mary K Willian
Journal:  Health Qual Life Outcomes       Date:  2008-10-02       Impact factor: 3.186

9.  Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.

Authors:  Richard Shikiar; Brian W Bresnahan; Stephen P Stone; Christine Thompson; John Koo; Dennis A Revicki
Journal:  Health Qual Life Outcomes       Date:  2003-10-08       Impact factor: 3.186

10.  Satisfaction with life in a group of psoriasis patients.

Authors:  Barbara Jankowiak; Sylwia Sekmistrz; Beata Kowalewska; Wiaczesław Niczyporuk; Elżbieta Krajewska-Kułak
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.